Introduction
Edaject contains the active ingredient Edaravone and is used in the treatment of certain conditions.
Uses
Edaject is prescribed to manage the symptoms associated with amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.
Dosage and Administration
The dosage and administration of Edaject should be determined by a healthcare professional based on the patient’s individual condition. It is typically administered intravenously over a specific period, as directed by a healthcare provider.
Mechanism of Action
Edaravone, the active ingredient in Edaject, is thought to exert its effects through its antioxidant properties, which may help mitigate oxidative stress and protect nerve cells from damage.
Side Effects
Common side effects of Edaject may include bruising at the injection site, headache, and dizziness. Serious side effects such as allergic reactions, difficulty breathing, or chest pain should be reported to a healthcare professional immediately.
Drug Interactions
It’s important to discuss any potential drug interactions with a healthcare provider before starting Edaject. Common drug interactions may occur with medications that affect blood clotting or other intravenous medications.
Precautions
Patients should inform their healthcare provider of any existing medical conditions or medications they are taking, especially those that may affect blood clotting or liver function. Edaject may not be suitable for individuals with certain allergies or sensitivities.
Storage
Edaject should be stored according to the manufacturer’s instructions, typically at controlled room temperature and protected from light.
Patient Tips
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Edaravone oral/injection (Drugs.com) [Accessed 16 Jun. 2024] (online) Available at:
- edaravone 105 mg/5 ml oral suspension (RX) [Accessed 15 Jun. 2024] (online) Available at:
- Edaravone Oral (MedlinePlus) [Accessed 28 Jun. 2024] (online) Available at:
- Dang R, Wang M, Li X, Wang H, Liu L, Wu Q, Zhao J, Ji P, Zhong L, Licinio J, Xie P. Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway. J Neuroinflammation. 2022 Feb 7;19(1):41. doi: 10.1186/s12974-022-02400-6. [Accessed 22 Jun. 2024] Available at:
Reviews
There are no reviews yet.